Related Experiment Videos
Expression of transgenes in human and rat retinal pigment epithelium in vitro using an adenoviral vector
L da Cruz1, P E Rakoczy, I J Constable
1Centre for Ophthalmology and Visual Sciences, Lions Eye Institute, Nedlands, Western Australia.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A review and update on the current status of stem cell therapy and the retina.
British medical bulletin·2012
Antisense DNA technology.
Methods in molecular medicine·2011
Linear IgA disease.
Australian and New Zealand journal of ophthalmology·2000
Ring keratitis from topical anaesthetic misuse.
Australian and New Zealand journal of ophthalmology·2000
Lamellar corneal autograft for corneal perforation.
Australian and New Zealand journal of ophthalmology·2000
Preretinal haemorrhages: an unusual manifestation of intravitreal amikacin toxicity.
Australian and New Zealand journal of ophthalmology·2000
Spontaneous suprachoroidal haemorrhage in a patient receiving low-molecular-weight heparin (fraxiparine) therapy.
Australian and New Zealand journal of ophthalmology·2000
Intravitreal triamcinolone and elevated intraocular pressure.
Australian and New Zealand journal of ophthalmology·2000
A logistic paradigm to predict molecular glioblastoma on clinical MRI.
Frontiers in oncology·2026
Single-NIR Triggered Triple-Modal Therapy: Synergistic PTT/PDT and Ultrafast Ag(II) Release via a Van Der Waals Silver Porphyrin/Graphene-TiO2 Heterojunction for MRSA-Infected Wounds.
Small (Weinheim an der Bergstrasse, Germany)·2026
Optimizing therapy in hidradenitis suppurativa: Combination, sequencing and treat-to-target.
Journal of the European Academy of Dermatology and Venereology : JEADV·2026
The Expanding Therapeutic Landscape in Myasthenia Gravis.
Muscle & nerve·2026
Effectiveness of Remdesivir in individuals with confirmed Omicron variant: a meta-analysis of cohort studies.
Expert review of anti-infective therapy·2026
Veligrotug: First Approval.
Drugs·2026